These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23889335)

  • 1. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.
    Weh E; Reis LM; Tyler RC; Bick D; Rhead WJ; Wallace S; McGregor TL; Dills SK; Chao MC; Murray JC; Semina EV
    Clin Genet; 2014 Aug; 86(2):142-8. PubMed ID: 23889335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome.
    Ben Mahmoud A; Siala O; Mansour RB; Driss F; Baklouti-Gargouri S; Mkaouar-Rebai E; Belguith N; Fakhfakh F
    Gene; 2013 Dec; 532(1):13-7. PubMed ID: 23954224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrocephalus, agenesis of the corpus callosum, and cleft lip/palate represent frequent associations in fetuses with Peters' plus syndrome and B3GALTL mutations. Fetal PPS phenotypes, expanded by Dandy Walker cyst and encephalocele.
    Schoner K; Kohlhase J; Müller AM; Schramm T; Plassmann M; Schmitz R; Neesen J; Wieacker P; Rehder H
    Prenat Diagn; 2013 Jan; 33(1):75-80. PubMed ID: 23161355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Tunisian patients with Peters plus syndrome harbouring a novel splice site mutation in the B3GALTL gene that modulates the mRNA secondary structure.
    Siala O; Belguith N; Kammoun H; Kammoun B; Hmida N; Chabchoub I; Hchicha M; Fakhfakh F
    Gene; 2012 Oct; 507(1):68-73. PubMed ID: 22759511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase.
    Zhang A; Venkat A; Taujale R; Mull JL; Ito A; Kannan N; Haltiwanger RS
    J Biol Chem; 2021 Jul; 297(1):100843. PubMed ID: 34058199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peters plus syndrome and Chorioretinal findings associated with B3GLCT gene mutation - a case report.
    Wang YE; Ramirez DA; Chang TC; Berrocal A
    BMC Ophthalmol; 2020 Mar; 20(1):118. PubMed ID: 32204707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertebral defects in patients with Peters plus syndrome and mutations in B3GALTL.
    Faletra F; Athanasakis E; Minen F; Fornasier F; Marchetti F; Gasparini P
    Ophthalmic Genet; 2011 Nov; 32(4):256-8. PubMed ID: 21671750
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe Peters Plus syndrome-like phenotype with anterior eye staphyloma and hypoplastic left heart syndrome: proposal of a new syndrome.
    Shimizu R; Saito R; Hoshino K; Ogawa K; Negishi T; Nishimura J; Mitsui N; Osawa M; Ohashi H
    Congenit Anom (Kyoto); 2010 Sep; 50(3):197-9. PubMed ID: 20584037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of a Novel
    Totoń-Żurańska J; Kapusta P; Rybak-Krzyszkowska M; Lorenc K; Machlowska J; Skalniak A; Filipek E; Pawlik D; Wołkow PP
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Phenotype of Peters-Plus Syndrome.
    Shah PR; Chauhan B; Chu CT; Kofler J; Nischal KK
    Cornea; 2022 Feb; 41(2):219-223. PubMed ID: 34629439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nonsense B3GALTL mutation confirms Peters plus syndrome in a patient with multiple malformations and Peters anomaly.
    Aliferis K; Marsal C; Pelletier V; Doray B; Weiss MM; Tops CM; Speeg-Schatz C; Lesnik SA; Dollfus H
    Ophthalmic Genet; 2010 Dec; 31(4):205-8. PubMed ID: 21067481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Presentation of Corneal Opacity in Peters Plus Syndrome: An Unusual Form of Peters Anomaly Showing Tissue Repair in Serial Analysis.
    de Nie KF; Wesseling P; Eggink CA
    Cornea; 2016 Feb; 35(2):277-80. PubMed ID: 26684045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism.
    Vasudevan D; Takeuchi H; Johar SS; Majerus E; Haltiwanger RS
    Curr Biol; 2015 Feb; 25(3):286-295. PubMed ID: 25544610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of B3GALTL in Peters Plus syndrome.
    Reis LM; Tyler RC; Abdul-Rahman O; Trapane P; Wallerstein R; Broome D; Hoffman J; Khan A; Paradiso C; Ron N; Bergner A; Semina EV
    Am J Med Genet A; 2008 Oct; 146A(20):2603-10. PubMed ID: 18798333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility gene card for: Peters plus syndrome.
    Jaeken J; Lefeber DJ; Matthijs G
    Eur J Hum Genet; 2016 Aug; 24(8):. PubMed ID: 27049305
    [No Abstract]   [Full Text] [Related]  

  • 16. Peters Plus syndrome: a recognizable clinical entity.
    Demir GÜ; Lafcı NG; Doğan ÖA; Şimşek-Kiper PÖ; Utine GE
    Turk J Pediatr; 2020; 62(1):136-140. PubMed ID: 32253880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome.
    Weh E; Takeuchi H; Muheisen S; Haltiwanger RS; Semina EV
    PLoS One; 2017; 12(9):e0184903. PubMed ID: 28926587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput miRFluR Platform Identifies miRNA Regulating B3GLCT That Predict Peters' Plus Syndrome Phenotype, Supporting the miRNA Proxy Hypothesis.
    Thu CT; Chung JY; Dhawan D; Vaiana CA; Mahal LK
    ACS Chem Biol; 2021 Oct; 16(10):1900-1907. PubMed ID: 34085516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase.
    Lesnik Oberstein SA; Kriek M; White SJ; Kalf ME; Szuhai K; den Dunnen JT; Breuning MH; Hennekam RC
    Am J Hum Genet; 2006 Sep; 79(3):562-6. PubMed ID: 16909395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.
    Holdener BC; Percival CJ; Grady RC; Cameron DC; Berardinelli SJ; Zhang A; Neupane S; Takeuchi M; Jimenez-Vega JC; Uddin SMZ; Komatsu DE; Honkanen R; Dubail J; Apte SS; Sato T; Narimatsu H; McClain SA; Haltiwanger RS
    Hum Mol Genet; 2019 Dec; 28(24):4053-4066. PubMed ID: 31600785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.